openPR Logo

Press Releases from Berlin Heart GmbH (8 total)

Personnel changes in the management board of Berlin Heart GmbH

As of October, 20th 2014 Mr. Sven-René Friedel and Dr. Ares K. Menon are appointed as new members of the management board. In addition to the finance and administration department, Mr. Friedel will be responsible for the departments Research & Development as well as Quality Management & Regulatory Affairs. Dr. Menon will be responsible for the departments Clinical Affairs & Clinical Science, Marketing & Sales, as well as Production. Each

1. Japanese EXCOR® Pediatric patient successfully transplanted

Berlin, 19.06.2013: The wait for a donor heart is over for the 1st Japanese patient treated with the EXCOR® Pediatric. On May 20th, 2013 the two-year-old girl was successfully transplanted at Morgan Stanley Childrens Hospital, New York Columbia Presbyterian Medical Center. According to the patient’s physicians, she tolerated the procedure well and is recovering as expected. In August 2012, for the first time in Japan’s history, it was possible

Successful air transport of the first Japanese baby with artificial heart to the …

Berlin, 07.03.2013: For the first time in the history of Japan the physicians Professor Murakami and Professor Ono of the University of Tokyo were able to save the life of an infant with severe heart failure with the help of a Berlin Heart EXCOR® Pediatric ventricular assist device in August 2012. The 21-month-old patient had fallen ill from a dilated cardiomyopathy and was successfully treated for almost six months at

Berlin Medical Technology Companies: State Secretary Nicolas Zimmer visits Berli …

Berlin, 11. October 2012: The State Secretary of the Senate Department for Economics, Technology and Research, Nicolas Zimmer, visited Berlin Heart GmbH in Steglitz last month in order to get acquainted on location with the product line-up, range of application and operating mode of mid-sized Berlin companies. In conversation with the management of Berlin Heart, the present possibilities for therapy of cardiac insufficiency with the ventricular assist device were presented. In

Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review

Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007,

Successful transatlantic EXCOR® air ambulance transportations

Berlin, 30 March 2011. Four young children suffering from severe heart failure and consequently supported by the EXCOR® ventricular assist device, were safely and successfully transported by aircraft during the last months. The so-called artificial heart was implanted in order to assist the patient’s heart function of pumping blood through the body. As a life-saving device, it bridges the time until a donor heart is found and transplantation becomes possible.

Youngest infant ever in Turkey receives the EXCOR® Pediatric Ventricular Assist …

Berlin, 19 July 2010. Prof. Mustafa Özbaran, leading surgeon of the VAD program at the EGE University Hospital in Izmir, successfully implanted the EXCOR® Pediatric device in the youngest Turkish patient since they started their ventricular assist device program. After his birth the patient, a 17-months-old boy was diagnosed with ideopathic cardiomyopathy, a severe form of heart failure which affects the vital function of the heart. The patient had to undertake

Second hospital in Izmir establishes VAD program for patients suffering from hea …

Berlin, 24 June 2010. The Dokuz Eylul University Hospital in Izmir (Turkey) has just initiated their VAD (Ventricular Assist Device) program. This is the second hospital in Izmir, which offers patients suffering from end-stage heart failure a life-saving therapy. The VAD systems are used for mechanical support of the heart function. In most cases these devices are implanted in order to bridge the waiting time for a matching donor heart in